Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

American College Of Cardiology 2004 Scientific Sessions In Brief

This article was originally published in The Gray Sheet

Executive Summary

Expanded Cypher use: Sirolimus-eluting stents are effective in treating lesions in relatively narrow vessels, according to eight-month data from the 257-patient SES-SMART trial comparing Johnson & Johnson/Cordis' Cypherwith the firm's bare-metal Bx Velocity. Binary restenosis was 9.8% and 53.1% for the Cypher and control groups, respectively; major cardiac event rates were 9.3% for Cypher and 31.3% for control. Mean vessel diameter was 2.2 mm; mean pre-procedure lumen diameter was 0.72 mm. Cypher currently is approved for vessels 2.5-3.5 mm in diameter...
Advertisement

Related Content

Tunis Praises NEJM Editorial Calling On Doctors To Care About Societal Costs
Tunis Praises NEJM Editorial Calling On Doctors To Care About Societal Costs
St. Jude To Announce RHYTHM Data As ACC Crowd Buzzes About SCD-HeFT
St. Jude To Announce RHYTHM Data As ACC Crowd Buzzes About SCD-HeFT
Advertisement
UsernamePublicRestriction

Register

MT019925

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel